Predicted protein targets (top 11)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | TFPI | P10646 | 1/20 | 0.65 |
| ▸ | GLP1R | P43220 | 2/20 | 0.62 |
| ▸ | GCGR | P47871 | 1/20 | 0.62 |
| ▸ | GIPR | P48546 | 1/20 | 0.62 |
| ▸ | PTH1R | Q03431 | 3/20 | 0.61 |
| ▸ | VIPR1 | P32241 | 2/20 | 0.60 |
| ▸ | CCKBR | P32239 | 1/20 | 0.59 |
| ▸ | RXFP1 | Q9HBX9 | 1/20 | 0.59 |
| ▸ | NR3C1 | P04150 | 2/20 | 0.58 |
| ▸ | VIPR2 | P41587 | 2/20 | 0.57 |
| ▸ | BACE1 | P56817 | 1/20 | 0.57 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL29640388 | 0.95 | TFPI (0.65) | TFPIGLP1RGCGRGIPRPTH1R | |
| SCHEMBL30607324 | 0.93 | VIPR1 (0.65) | GLP1RGCGRGIPRPTH1RVIPR1 | |
| SCHEMBL29851163 | 0.92 | TFPI (0.71) | TFPIGLP1RPTH1RVIPR1NR3C1 | |
| SCHEMBL29551264 | 0.92 | TFPI (0.71) | TFPIGLP1RPTH1RVIPR1NR3C1 | |
| SCHEMBL29701273 | 0.91 | TFPI (0.74) | TFPIGLP1RGCGRGIPRPTH1R | |
| SCHEMBL31678895 | 0.91 | TFPI (0.60) | TFPIGLP1RGCGRGIPRPTH1R | |
| SCHEMBL30431350 | 0.91 | OPRL1 (0.59) | TFPIGLP1RGCGRGIPRPTH1R | |
| SCHEMBL30495615 | 0.91 | TFPI (0.62) | TFPIGLP1RGCGRGIPRPTH1R | |
| SCHEMBL29949376 | 0.91 | GLP1R (0.63) | TFPIGLP1RGCGRGIPRPTH1R | |
| SCHEMBL30277897 | 0.91 | TFPI (0.60) | TFPIGLP1RGCGRGIPRPTH1R |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20240350475-A1 | TRIGONELLINE MITIGATES CARDIOMYOPATHY CAUSED BY SARS-COV-2 SPIKE PROTEIN UNDER OBESITY | UNIVERSITY OF SOUTH CAROLINA (US) | 2024-10-24 | — | — | US | disclosed |